AGM/EGMJun 23, 2026, 06:07 AM
XTL Biopharmaceuticals EGM Adjourned Due to Lack of Quorum
AI Summary
XTL Biopharmaceuticals Ltd. announced that its Extraordinary General Meeting of Shareholders, convened on June 22, 2026, was adjourned. The adjournment was due to a lack of quorum. The meeting will be reconvened on Monday, June 29, 2026, at 4:00 p.m. Israel time, at the offices of Amit, Pollak, Matalon & Co. in Tel Aviv.
Key Highlights
- XTL Biopharmaceuticals Ltd. convened an Extraordinary General Meeting (EGM) on June 22, 2026.
- The EGM was adjourned due to a lack of quorum.
- The meeting will be reconvened on Monday, June 29, 2026, at 4:00 p.m. Israel time.
- The reconvened EGM will take place at the offices of Amit, Pollak, Matalon & Co. in Tel Aviv.
Price Impact
More from XTLB